SEC Form 10-K filed by Jupiter Neurosciences Inc.
$JUNS
Biotechnology: Pharmaceutical Preparations
Health Care
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company pioneering therapies for central nervous system (CNS) disorders and advancing science-based consumer health solutions, today announced a pivotal expansion of its dual-path business model with the launch of its dedicated Nugevia™ e-commerce website, www.nugevia.com, and the opening of pre-orders for its first three nutraceutical supplements: Nugevia™ GLO, Nugevia™ PWR, and Nugevia™ MND. The products are available for purchase via subscription or as a one-time order, with shipp
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) today announced that Chris Webber, five-time NBA All-Star and Hall of Fame inductee, has joined the Company as the second official brand ambassador for Nugevia™, Jupiter Neurosciences' new consumer longevity supplement line. Webber, who played 15 seasons in the National Basketball Association, including standout years with the Sacramento Kings, brings his championship mindset and commitment to peak performance to the Nugevia mission. Over his career, Webber was
MND combines proprietary resveratrol-based platform and NovaSOL® Curcumin to enhance cognitive performance and support neuroprotective health Jupiter, Florida, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, today introduced Nugevia™ MND, a scientifically formulated supplement designed to protect and enhance cognitive function and support overall brain health. MND addresses the surging consumer demand for clinically validated cognitive wellness solutions, opening up significant market opportunities in the rapidly growing $8 trillion l
10-Q - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
NT 10-Q - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
8-K - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)